Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)

Taiwan · Delayed Price · Currency is TWD

30.10

-0.40 (-1.31%)

Oct 30, 2026, 1:30 PM CST

Market Cap	3.04B -22.5%
Revenue (ttm)	2.11B -7.5%
Net Income	205.39M -23.5%
EPS	2.03 -23.1%
Shares Out	100.99M
PE Ratio	14.82
Forward PE	n/a
Dividend	1.60 (5.32%)
Ex-Dividend Date	Jul 2, 2026

Volume	117,647
Open	30.80
Previous Close	30.50
Day's Range	30.00 - 30.80
52-Week Range	30.00 - 39.25
Beta	0.13
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Nang Kuang Pharmaceutical

Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion. It also provides various products in the areas of cardiovascular, gastrointestinal, nervous, musculo-skeletal, and respiratory system, as well as in a... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1963

Employees 552

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 1752

Full Company Profile

Financial Performance

In 2025, Nang Kuang Pharmaceutical's revenue was 2.16 billion, a decrease of -1.71% compared to the previous year's 2.20 billion. Earnings were 244.41 million, an increase of 0.41%.

Financial Statements